Lipidated peptides for lowering blood glucose
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F17%3A00484673" target="_blank" >RIV/61388963:_____/17:00484673 - isvavai.cz</a>
Alternative codes found
RIV/67985823:_____/17:00484673
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=AU&NR=2015207776B2&KC=B2&FT=D&ND=4&date=20170615&DB=EPODOC&locale=en_EP#" target="_blank" >https://worldwide.espacenet.com/publicationDetails/biblio?CC=AU&NR=2015207776B2&KC=B2&FT=D&ND=4&date=20170615&DB=EPODOC&locale=en_EP#</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Lipidated peptides for lowering blood glucose
Original language description
Lipidated analogs of prolactin-releasing peptides (PrRP) and their use in controlling and lowering blood glucose in mammals is disclosed. Useful compounds included lipidated analogs of PrRP20 and PrRP31. Pharmacological effects are demonstrated both in vitro and in vivo. Peripheral administration of the lipidated analog of prolactin releasing peptide (PrRP)s lowers blood glucose levels. These treatments are applicable for treating impaired glucose tolerance (IGT), and glucose intolerance condition. The disclosed compounds have application in treating medical conditions including diabetes, pre-diabetes, eating disorders, and obesity.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
<a href="/en/project/TE01020028" target="_blank" >TE01020028: Center for Development of Original Drugs</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
AU2015207776
Publisher
AU001 -
Publisher name
IP Australia
Place of publication
Phillip ACT
Publication country
AU - AUSTRALIA
Date of acceptance
Jun 15, 2017
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i. - Fyziologický ústav AV ČR, v. v. i
Method of use
B - Výsledek je využíván orgány státní nebo veřejné správy
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence